Aleksandra Butrym, MD, PhD

Department of Cancer Prevention and Therapy, Wroclaw Medical University; Alfred Sokolowski Specialist Hospital in Walbrzych Oncology Support Centre for Clinical Trials, Poland

Poster(s):

• 1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group